{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:08:45Z","timestamp":1790968125301,"version":"4.1.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>Vulvar intraepithelial neoplasia (VIN) is an increasingly common problem, particularly among women in their 40s. Although spontaneous regression has been reported, VIN should be considered a premalignant condition. Immunization with the quadrivalent or 9-valent human papillomavirus vaccine, which is effective against human papillomavirus genotypes 6, 11, 16, and 18, and 6, 11, 16, 18, 31, 33, 45, 52, and 58, respectively, has been shown to decrease the risk of vulvar high-grade squamous intraepithelial lesion (HSIL) (VIN usual type) and should be recommended for girls aged 11\u201312 years with catch-up through age 26 years if not vaccinated in the target age. There are no screening strategies for the prevention of vulvar cancer through early detection of vulvar HSIL (VIN usual type). Detection is limited to visual assessment with confirmation by histopathology when needed. Treatment is recommended for all women with vulvar HSIL (VIN usual type). Because of the potential for occult invasion, wide local excision should be performed if cancer is suspected, even if biopsies show vulvar HSIL. When occult invasion is not a concern, vulvar HSIL (VIN usual type) can be treated with excision, laser ablation, or topical imiquimod (off-label use). Given the relatively slow rate of progression, women with a complete response to therapy and no new lesions at follow-up visits scheduled 6 months and 12 months after initial treatment should be monitored by visual inspection of the vulva annually thereafter.<\/jats:p>","DOI":"10.1097\/aog.0000000000001713","type":"journal-article","created":{"date-parts":[[2016,9,23]],"date-time":"2016-09-23T09:26:20Z","timestamp":1474622780000},"page":"e178-e182","source":"Crossref","is-referenced-by-count":73,"title":["Committee Opinion No.675: Management of Vulvar Intraepithelial Neoplasia"],"prefix":"10.1097","volume":"128","member":"276","reference":[{"key":"R1-20230711","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/01.AOG.0000210268.57527.a1","article-title":"Trends in the incidence of invasive and in situ vulvar carcinoma","volume":"107","author":"Judson","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R2-20230711","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/01.AOG.0000187301.76283.7f","article-title":"Vulvar intraepithelial neoplasia: aspects of the natural history and outcome in 405 women","volume":"106","author":"Jones","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R3-20230711","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.ygyno.2005.02.012","article-title":"Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence? A systematic review of 3322 published patients","volume":"97","author":"van Seters","year":"2005","journal-title":"Gynecol Oncol"},{"key":"R4-20230711","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/AOG.0000000000001285","article-title":"The 2015 International Society for the Study of Vulvovaginal Disease (ISSVD) terminology of vulvar squamous intraepithelial lesions. ISSVD Terminology Committee","volume":"127","author":"Bornstein","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R5-20230711","first-page":"807","article-title":"Squamous vulvar intraepithelial neoplasia: 2004 modified terminology, ISSVD Vulvar Oncology Subcommittee","volume":"50","author":"Sideri","year":"2005","journal-title":"J Reprod Med"},{"key":"R6-20230711","first-page":"397","article-title":"Vulval squamous cell carcinoma occurring on a background of differentiated vulval intraepithelial neoplasia is more likely to recur: a review of 154 cases","volume":"53","author":"Eva","year":"2008","journal-title":"J Reprod Med"},{"key":"R7-20230711","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1158\/1055-9965.EPI-09-0209","article-title":"The etiologic role of HPV in vulvar squamous cell carcinoma fine tuned","volume":"18","author":"van de Nieuwenhof","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R8-20230711","first-page":"1338","article-title":"Practice Bulletin No. 140. American College of Obstetricians and Gynecologists","volume":"122","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R9-20230711","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/jnci\/djp534","article-title":"Impact of human papillomavirus (HPV)-6\/11\/16\/18 vaccine on all HPV-associated genital diseases in young women","volume":"102","author":"Munoz","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"R10-20230711","first-page":"e38","article-title":"Committee Opinion No. 641. American College of Obstetricians and Gyne-cologists","volume":"126","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R11-20230711","first-page":"140","article-title":"Risk factors for recurrent VIN. Role of multifocality and grade of disease","volume":"42","author":"Kuppers","year":"1997","journal-title":"J Reprod Med"},{"key":"R12-20230711","first-page":"962","article-title":"Vulvar intraepithelial neoplasia III: occult cancer and the impact of margin status on recurrence","volume":"92","author":"Modesitt","year":"1998","journal-title":"Obstet Gynecol"},{"key":"R13-20230711","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1097\/01.AOG.0000258783.49564.5c","article-title":"Surgical treatments for vulvar and vaginal dysplasia: a randomized controlled trial","volume":"109","author":"von Gruenigen","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R14-20230711","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jamadermatol.2015.0643","article-title":"Long-term management of adult vulvar lichen sclerosus: a prospective cohort study of 507 women","volume":"151","author":"Lee","year":"2015","journal-title":"JAMA Dermatol"},{"key":"R15-20230711","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1006\/gyno.1999.5584","article-title":"Evaluation of CO(2) laser excision or vaporization for the treatment of vulvar intraepithelial neoplasia","volume":"75","author":"Sideri","year":"1999","journal-title":"Gynecol Oncol"},{"key":"R16-20230711","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/0002-9378(85)90616-7","article-title":"Superficial laser vulvectomy. III. A new surgical technique for appendage-conserving ablation of refractory condylomas and vulvar intraepithelial neoplasia","volume":"152","author":"Reid","year":"1985","journal-title":"Am J Obstet Gynecol"},{"key":"R17-20230711","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJMoa072685","article-title":"Treatment of vulvar intraepithelial neoplasia with topical imiquimod","volume":"358","author":"van Seters","year":"2008","journal-title":"N Engl J Med"},{"key":"R18-20230711","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ygyno.2007.06.003","article-title":"Topical imiquimod can reverse vulvar intraepithelial neoplasia: a randomised, double-blinded study","volume":"107","author":"Mathiesen","year":"2007","journal-title":"Gynecol Oncol"},{"key":"R19-20230711","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ygyno.2005.08.012","article-title":"Evaluation of different treatment modalities for vulvar intraepithelial neoplasia (VIN): CO(2) laser vaporization, photodynamic therapy, excision and vulvectomy","volume":"100","author":"Hillemanns","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R20-20230711","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/00006254-198504000-00002","article-title":"A review of lower genital intraepithelial neoplasia and the use of topical 5-fluorouracil","volume":"40","author":"Sillman","year":"1985","journal-title":"Obstet Gynecol Surv"},{"key":"R21-20230711","first-page":"702","article-title":"5-fluorouracil topical treatment of in situ vulvar cancer. A preliminary report","volume":"51","author":"Krupp","year":"1978","journal-title":"Obstet Gynecol"},{"key":"R22-20230711","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.ygyno.2005.07.127","article-title":"Clinical responses to Cidofovir applied topically to women with high grade vulval intraepithelial neoplasia","volume":"99","author":"Tristram","year":"2005","journal-title":"Gynecol Oncol"},{"key":"R23-20230711","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijgo.2007.03.023","article-title":"HPV-related vulvar intraepithelial neoplasia: outcome of different management modalities","volume":"99","author":"Bruchim","year":"2007","journal-title":"Int J Gynaecol Obstet"},{"key":"R24-20230711","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1097\/IGC.0b013e3182a57fd6","article-title":"Clinical characteristics associated with development of recurrence and progression in usual-type vulvar intraepithelial neoplasia","volume":"23","author":"van Esch","year":"2013","journal-title":"Int J Gynecol Cancer"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006250-201610000-00063","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T19:53:17Z","timestamp":1689105197000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201610000-00063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000001713","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]}}}